Patents Assigned to Cancer Targered Technology LLC
  • Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use
    Patent number: 7696185
    Abstract: Compounds of the formula, A—L—B, wherein A is glutamate or a glutamate analog; L is a phosphoramidate or a phosphoramidate analog; and B is serine or a serine analog are described which are potent inhibitors of prostate-specific membrane antigen (PMSA). Such compounds are useful in treatment of prostate cancer; and when chemically attached to a fluorescent dye, can efficiently and selectively label prostate cancer cells for fluorescent imaging.
    Type: Grant
    Filed: March 14, 2007
    Date of Patent: April 13, 2010
    Assignee: Cancer Targered Technology LLC
    Inventor: Cliff Berkman